This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Novozymes probed in Turkey over discount scheme that might have exclusionary effects

( May 13, 2024, 07:33 GMT | Official Statement) -- MLex Summary: Enzymes producer Novozymes is the target of a Turkish antitrust investigation, to determine whether it has abused its dominant position by applying a discount system for buyers in the flour and bakery sector. According to the authority, this scheme "was designed to create high levels of loyalty and to potentially exclude competitors from the market."See press statement....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections